Join to View Full Profile
800 Washington StBoston, MA 02111
Phone+1 617-636-8884
Dr. Martell is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Duke University HospitalFellowship, Hematology and Medical Oncology, 1997 - 1999- Duke University HospitalResidency, Internal Medicine, 1993 - 1996
Wayne State University School of MedicineClass of 1993
Certifications & Licensure
VT State Medical License 2023 - 2026
MA State Medical License 2009 - 2024
CT State Medical License 2000 - 2010
NC State Medical License 1998 - 2001
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery Start of enrollment: 2009 Oct 28
- Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery Start of enrollment: 2010 Jun 01
- Impact of Pretreatment With Metformin on Colorectal Cancer Stem Cells (CCSC) and Related Pharmacodynamic Markers Start of enrollment: 2011 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- 20 citationsVISTA expression and patient selection for immune-based anticancer therapy.Alexander S Martin, Michael Molloy, Andrey Ugolkov, Reinhard W von Roemeling, Randolph J Noelle
Frontiers in Immunology. 2023-01-01 - 6 citationsClinical and research updates on the VISTA immune checkpoint: immuno-oncology themes and highlights.Randolph J Noelle, J Louise Lines, Lionel D Lewis, Robert E Martell, Thierry Guillaudeux
Frontiers in Oncology. 2023-01-01 - Correction: Innate immune mediator, Interleukin-1 receptor accessory protein (IL1RAP), is expressed and pro-tumorigenic in pancreatic cancer.Yang Zhang, Xiaoyi Chen, Huamin Wang, Shanisha Gordon-Mitchell, Srabani Sahu
Journal of Hematology & Oncology. 2022-07-26
Press Mentions
Curis to Host Webcast to Discuss Updated Emavusertib Clinical Data in LeukemiaDecember 6th, 2022- Curis Will Host a Webcast to Discuss Updated Clinical Data on Emavusertib in the Treatment of LeukemiaJune 12th, 2022
Curis : To Present at the 6th Annual OMI Summit on Hematologic MalignanciesMarch 15th, 2019- Join now to see all
Grant Support
- Ezf Family Of Genes And Cellular SenescenceNational Institute On Aging1999–2000
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
